- Home
- SABS vs LOBO Comparison
SABS vs LOBO Comparison
Compare SABS & LOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- LOBO
- Stock Information
- Founded
- SABS 2014
- LOBO 2014
- Country
- SABS United States
- LOBO China
- Employees
- SABS N/A
- LOBO N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- LOBO
- Sector
- SABS Health Care
- LOBO
- Exchange
- SABS Nasdaq
- LOBO NYSE
- Market Cap
- SABS 11.4M
- LOBO 13.6M
- IPO Year
- SABS N/A
- LOBO 2024
- Fundamental
- Price
- SABS $1.37
- LOBO $0.80
- Analyst Decision
- SABS Strong Buy
- LOBO
- Analyst Count
- SABS 5
- LOBO 0
- Target Price
- SABS $11.40
- LOBO N/A
- AVG Volume (30 Days)
- SABS 25.6K
- LOBO 52.0K
- Earning Date
- SABS 05-19-2025
- LOBO 04-29-2025
- Dividend Yield
- SABS N/A
- LOBO N/A
- EPS Growth
- SABS N/A
- LOBO N/A
- EPS
- SABS N/A
- LOBO 0.00
- Revenue
- SABS $1,322,410.00
- LOBO $19,469,766.00
- Revenue This Year
- SABS N/A
- LOBO $72.16
- Revenue Next Year
- SABS $50.00
- LOBO $41.04
- P/E Ratio
- SABS N/A
- LOBO $741.89
- Revenue Growth
- SABS N/A
- LOBO N/A
- 52 Week Low
- SABS $1.00
- LOBO $0.46
- 52 Week High
- SABS $5.01
- LOBO $3.52
- Technical
- Relative Strength Index (RSI)
- SABS 46.90
- LOBO N/A
- Support Level
- SABS $1.30
- LOBO N/A
- Resistance Level
- SABS $1.49
- LOBO N/A
- Average True Range (ATR)
- SABS 0.13
- LOBO 0.00
- MACD
- SABS 0.04
- LOBO 0.00
- Stochastic Oscillator
- SABS 75.51
- LOBO 0.00
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About LOBO LOBO EV TECHNOLOGIES LTD
Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.